Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             29 results found
no title author magazine year volume issue page(s) type
1 Aberrant GSK3β nuclear localization promotes AML growth and drug resistance Ignatz-Hoover, James J.

2 21 p. 2890-2903
article
2 Activity of eltrombopag in severe aplastic anemia Scheinberg, Phillip

2 21 p. 3054-3062
article
3 A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease Baker, Turner S.

2 21 p. 2959-2963
article
4 Antibody-mediated immune suppression by antigen modulation is antigen-specific Maier, Cheryl L.

2 21 p. 2986-3000
article
5 CD16+ monocytes give rise to CD103+RALDH2+TCF4+ dendritic cells with unique transcriptional and immunological features Wacleche, Vanessa Sue

2 21 p. 2862-2878
article
6 Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1 Su, Hairui

2 21 p. 2829-2836
article
7 Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial Voskaridou, Ersi

2 21 p. 2837-2847
article
8 Driver mutations in Janus kinases in a mouse model of B-cell leukemia induced by deletion of PU.1 and Spi-B Batista, Carolina R.

2 21 p. 2798-2810
article
9 Editorial Board
2 21 p. i
article
10 High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1) Zhi, Huiying

2 21 p. 3001-3011
article
11 Impact of somatic and germline mutations on the outcome of systemic mastocytosis Muñoz-González, Javier I.

2 21 p. 2814-2828
article
12 Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia Hunter, Zachary R.

2 21 p. 2937-2946
article
13 Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models Pardanani, Animesh

2 21 p. 2964-2972
article
14 Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia Chhabra, Saurabh

2 21 p. 2922-2936
article
15 Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow Mazzotti, Céline

2 21 p. 2811-2813
article
16 Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate Bendapudi, Pavan K.

2 21 p. 2917-2921
article
17 Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo Yang, Moua

2 21 p. 2848-2861
article
18 Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children McGann, Patrick T.

2 21 p. 3035-3044
article
19 Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization Kis-Toth, Katalin

2 21 p. 2904-2916
article
20 Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia Matsuo, Hidemasa

2 21 p. 2879-2889
article
21 Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia Maharaj, Kamira

2 21 p. 3012-3024
article
22 SNARE-dependent membrane fusion initiates α-granule matrix decondensation in mouse platelets Pokrovskaya, Irina D.

2 21 p. 2947-2958
article
23 Stem cell safe harbor: the hematopoietic stem cell niche in zebrafish Wattrus, Samuel J.

2 21 p. 3063-3069
article
24 The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation Salamah, Maryam F.

2 21 p. 2973-2985
article
25 Timing of treatment of smoldering myeloma: delay until progression Kumar, Shaji K.

2 21 p. 3050-3053
article
26 Timing of treatment of smoldering myeloma: early treatment Mateos, María-Victoria

2 21 p. 3045-3049
article
27 Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study Gade, Inger Lise

2 21 p. 3025-3034
article
28 When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter Roloff, Gregory W.

2 21 p. 3070-3080
article
29 Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Rodger, Marc Alan

2 21 p. 3081-3087
article
                             29 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands